Plenary Speakers

Amir Hamzah  Abdul Lattif

Amir Hamzah Abdul Lattif

Malaysia

Carina Venter

United States

Cezmi  Akdis

Cezmi Akdis

Switzerland

G. Walter Canonica

Italy

Hae-Sim  Park

Hae-Sim Park

South Korea

Luo  Zhang

Luo Zhang

China

Mário  Morais-Almeida

Mário Morais-Almeida

Portugal

Mubeccel  Akdis

Mubeccel Akdis

Switzerland

Ruby  Pawankar

Ruby Pawankar

Japan

Valerie Verhasselt

Australia

Amir Hamzah  Abdul Lattif

Plenary Speakers

Amir Hamzah Abdul Lattif

President

Asia Pacific Association Of Allergy, Asthma And Clinical Immunology

Malaysia

Dr Amir is a Consultant Clinical Immunologist, Allergist and Paediatrician at the Allergy & Immunology Centre, Pantai Hospital Kuala Lumpur, and Adjunct Professor at the Sunway Centre for Planetary Health, Sunway University Malaysia. He is the current President of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), and Fellows of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. He currently serves as Associate Editor of Asia Pacific Allergy (AP Allergy) and Review Editor of Frontiers in Allergy (Food Allergy). Dr Amir has over 120 publications in both international and national journals, with special interests in chronic urticaria, inborn errors of immunity (IEI) and planetary health. Focused on planetary health, his work examines how climate change, air pollution, and biodiversity loss impact human well-being, especially in children—while identifying health co-benefits in environmental solutions.

Plenary Speakers

Carina Venter

United States

Cezmi  Akdis

Plenary Speakers

Cezmi Akdis

Director

Swiss Institute Of Allergy And Asthma Research

Switzerland

Prof. Cezmi Akdis is the director of the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos and Professor in Zurich University Medical Faculty. He has honorary professorships from Beijign Cantional University Tongren Hospital (China), Wuhan University (China), Zhejiang University (Hangzhou, China) Bursa Uludag University (Turkey), Peking University, China and Harvard University (USA). He is a Senate Member of the Swiss Academy of Medical Sciences. Cezmi Akdis has published more than 800 peer-reviewed articles. His h-index is 173 (Scholar one) 138 (Web of Science). Cezmi Akdis acted as the President of the European Academy of Allergy & Clinical Immunology (20’000 members) between 2011-2013. He is a senate member of the Swiss Academy of Medical Sciences. He was the editor of Global Atlases of Allergy, Asthma I-II, Chronic Rhinosinusitis and Allergic Rhinitis, Planetary Health, and Co-Editor of Pediatric Allergy. He was the founder and organizer of the World Immune Regulation Meetings, Davos I-XX. He was the Editor-in-Chief of Journal of Allergy and Clinical Immunology and is currently the Editor-in-Chief of the Allergy journal. Cezmi Akdis’s current research is the continuation of his epithelial barrier theory development of allergic and autoimmune diseases. He has recently identified 80 diseases linked to Epithelial Barrier Damage and Microbial Dysbiosis overall are responsible for more than 2 billion patients. Cezmi Akdis is currently focused on development of AI solutions to better understand the mechanisms of diseases linked to epithelial barrier defect caused by environmental changes. His major contributions include immune tolerance to allergens, understanding of Type 2 immunity, discovery or first time demonstration of many human immune system cells and cell subsets and many articles at the early stages of Covid including the first human to human infection paper. Website: www.epithelialbarriertheory.com en.wikipedia.org/wiki/Cezmi_Akdis

Plenary Speakers

G. Walter Canonica

Italy

Hae-Sim  Park

Plenary Speakers

Hae-Sim Park

Professor

Ajou University Medical Center

South Korea

Dr. Hae-Sim Park is the Professor of the Department of Allergy & Clinical Immunology at Ajou University Medical Centre, South Korea. In clinical science, she has been recognized as a top-ranked allergy specialist and devoted as national and regional principal investigators in early clinical trials, and real-world studies for asthma, chronic urticaria and comorbid conditions, including chronic rhinosinusitis. Regarding translational research activities, she has concentrated on three fields, 1) the pathogenic mechanisms and biomarker validation for severe asthma, and N-ERD/NSAID hypersensitivity, 2) development of novel immunomodulators for severe asthma and chronic urticaria. She has published more than 400 peer-reviewed articles, and is a leading author of major textbooks including Middleton’s textbook of allergy. In addition, she has served on reviewers/editors of leading allergy journals and had devoted as an editor-in-chief of Allergy Asthma Immunol Research for 7 years (2014-2020) to promote this journal to international scale.
Luo  Zhang

Plenary Speakers

Luo Zhang

President

Capital Medical University

China

Professor Luo Zhang, MD, PhD serves as President of Capital Medical University. With an H-index of 72, Professor Zhang leads the Departments of Otolaryngology–Head and Neck Surgery and Allergy at Beijing Tongren Hospital. His research group has produced over 490 peer-reviewed publications, including articles in Nature, JAMA, and Nature Medicine. His research has focused on the pathophysiology of chronic rhinosinusitis, the regulation of airway ciliary activity, mechanisms of specific-allergen immunotherapy of allergic rhinitis, and surgical techniques of endoscopic sinus surgery. He is the President of the Chinese Society of Otorhinolaryngology-Head and Neck Surgery, Chinese Medical Doctor Association; President-elect of the Chinese Allergy Society (CAS); Vice President of the Chinese Society of Otorhinolaryngology-Head and Neck Surgery, Chinese Medical Association; President-elect of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI); Editor-in-Chief of Asia Pacific Allergy and Associate Editor of Allergy.
Mário  Morais-Almeida

Plenary Speakers

Mário Morais-Almeida

President

World Allergy Organization (WAO)

Portugal

President, World Allergy Organization (WAO), 2025–2026. Founder and Director of the Allergy and Clinical Immunology Centre, Hospital CUF Descobertas, Lisbon; recognised as a WAO Center of Excellence since 2016. Former President, Portuguese Society of Allergy and Clinical Immunology (SPAIC); Luso-Brazilian Society of Allergy and Clinical Immunology; and College of Allergy and Clinical Immunology of the Portuguese Medical Association. Former Vice-President, Latin American Society of Allergy, Asthma and Immunology. Contributor to international initiatives including ARIA and GINA. Author or co-author of more than 300 indexed scientific publications. Research interests include asthma, allergic rhinitis, food allergy, immunotherapy, biologic therapies, clinical remission, precision medicine and inequalities in access to allergy care.
Mubeccel  Akdis

Plenary Speakers

Mubeccel Akdis

Head Of Immune Regulation

SIAF

Switzerland

Dr Akdis is working in the Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich since 1995 and received her PhD in Immunology. She worked as a postdoctoral scientist and became a group leader at SIAF, where she has established her own research group in 2003. Dr Akdis made her habilitation in Zurich University Medical Faculty on Experimental Immunology in 2005 and became a professor in 2016. She has published 389 peer-reviewed articles, sum of times cited: 33'143 and her h-index: 99 (135- Google Scholar). She has received honorary professorships from Beijign Cantional University Tongren Hospital (China), Wuhan University (China), Zhejiang University (Hangzhou, China), Bursa Uludag University (Turkey), and Harvard University (USA). She has received research grants and collaborative grants from the Swiss National Foundation, European Union (6 consortium grants) and Stanford University Sean Parker Seed Grant. She received numerous awards, including International Distinguished Fellow Award of the American College of Allergy, Asthma & Immunology (ACAAI. European Academy of Allergy and Clinical Immunology EAACI, Paul Ehrlich Award for Experimental Research, Federation of European Biochemical Societies (FEBS) Datta Lecture and Medal, Kanton Graubünden Scientific Recognition Award, Sedat Simavi and Bulent Eczacibasi Medical Science Awards. She is currently scientific program co-chair of the EAACI. Her major contributions are on mechanisms of immune tolerance to allergens, viral infection responses of B cells, human B regulatory cells, mechanisms of allergen Immunotherapy and the role of antigen-specific B cells, immune tolerance to food antigens, regulation and subsets of IgG4 memory B cells.
Ruby  Pawankar

Plenary Speakers

Ruby Pawankar

Japan

Plenary Speakers

Valerie Verhasselt

Australia